Recurex SPRL
The score of Recurex shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2022 → 2024: Total assets +34 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Recurex's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 18 Aug 2024
- Year ended 31 Mar 2022filed on 30 Nov 2022
- Year ended 31 Dec 2020filed on 30 Aug 2021
- Year ended 31 Dec 2019filed on 17 Sep 2020
Recurex's financial analysis
- Solvency-2375.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Recurex
Recurex's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0823.449.331
- VAT number
- BE0823449331
- Peppol
- Not found on Peppol as of 06 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 25 Feb 2010
- Registered office
- 3090 Overijse
- Latest accounts
- 2024 · filed on 28 Aug 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Recurex (SPRL) has been based in Overijse since 2010, active in: retail sale of pharmaceutical products. For 2024, it reports a net loss of 3,293 € and equity of −79,371 €; its revenue is not published. Its solvency stands at -2375.2%, below the median of its sector (44.2%).
Companies similar to Recurex
Companies in the same business, of comparable size and area, outside its group.
- Ahonzo Corporate Retail sale of pharmaceutical products Etterbeek · balance sheet 49,700 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Dynamo Medical Other non-specialised retail sale Kortrijk · balance sheet 25,094 €
- Apropeau Wholesale of pharmaceutical and medical goods Leuven · balance sheet 1,902 €
- PMI Construction Retail sale of pharmaceutical products Arlon · balance sheet 11,405 €
- Dynaderm Retail sale of pharmaceutical products Wavre · balance sheet 47,613 €
- NN Phar Retail sale of pharmaceutical products Éghezée · balance sheet 16,773 €
- Quality Pharmaceutical Service Retail sale of pharmaceutical products La Bruyère · balance sheet 110,124 €
Frequently asked questions about Recurex
What is the revenue of Recurex?
Recurex files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Recurex?
In Belgium, the VAT number is the company number prefixed with BE: BE0823449331 for Recurex, if the company is VAT-registered. Its company number (CBE) is 0823.449.331.
Where is the registered office of Recurex?
According to the CBE register, the registered office of Recurex is in 3090 Overijse.
What is the equity of Recurex?
At the close of the 2024 financial year, the equity of Recurex amounts to -79,371 €, a solvency of -2375.2% of total assets.
Who manages Recurex?
The register lists 1 active mandates at Recurex. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Recurex
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →